Rockefeller Capital Management L.P. lessened its holdings in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 24.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,172,044 shares of the company's stock after selling 1,332,793 shares during the quarter. Rockefeller Capital Management L.P. owned 3.49% of SunOpta worth $32,123,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the business. BNP Paribas Financial Markets increased its stake in SunOpta by 33.8% in the third quarter. BNP Paribas Financial Markets now owns 45,627 shares of the company's stock valued at $291,000 after acquiring an additional 11,518 shares during the period. Verition Fund Management LLC bought a new stake in shares of SunOpta in the 3rd quarter valued at approximately $164,000. Quantinno Capital Management LP raised its holdings in shares of SunOpta by 33.1% in the 3rd quarter. Quantinno Capital Management LP now owns 13,522 shares of the company's stock worth $86,000 after buying an additional 3,360 shares in the last quarter. State Street Corp lifted its position in shares of SunOpta by 18.9% during the 3rd quarter. State Street Corp now owns 1,827,273 shares of the company's stock worth $11,658,000 after buying an additional 290,372 shares during the period. Finally, EP Wealth Advisors LLC acquired a new stake in SunOpta in the 3rd quarter valued at $79,000. Institutional investors and hedge funds own 85.39% of the company's stock.
SunOpta Price Performance
NASDAQ STKL traded up $0.02 during trading hours on Friday, reaching $3.90. 650,213 shares of the company's stock were exchanged, compared to its average volume of 758,524. The firm has a fifty day moving average of $5.45 and a 200-day moving average of $6.60. SunOpta Inc. has a one year low of $3.65 and a one year high of $8.11. The stock has a market cap of $467.04 million, a PE ratio of -21.67 and a beta of 1.83. The company has a current ratio of 1.20, a quick ratio of 0.53 and a debt-to-equity ratio of 1.61.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last announced its earnings results on Wednesday, February 26th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. The company had revenue of $193.91 million for the quarter, compared to analysts' expectations of $189.90 million. On average, equities research analysts predict that SunOpta Inc. will post 0.13 earnings per share for the current fiscal year.
Insider Activity
In related news, SVP Bryan P. Clark sold 8,500 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $5.32, for a total value of $45,220.00. Following the transaction, the senior vice president now owns 28,150 shares in the company, valued at $149,758. This trade represents a 23.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 6.48% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
STKL has been the subject of several recent analyst reports. StockNews.com upgraded SunOpta from a "sell" rating to a "hold" rating in a research note on Tuesday, March 11th. Stephens reissued an "overweight" rating and set a $10.00 price target on shares of SunOpta in a report on Thursday, January 2nd.
View Our Latest Analysis on SunOpta
About SunOpta
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Recommended Stories

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.